Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research Council of Norway
Grant: 245942/F50
Czech Science Foundation
Grant: 17-09998S
Charles University
Grant: SVV260440
Czech Science Foundation
Grant: 17-07164S
National sustainability program I
Grant: POLYMAT LO1507
Czech Academy of Sciences
Grant: TWN-18-10
Czech Academy of Sciences
Grant: VAJVA-19-55
NIH HHS
Grant: S10 OD023524
Ministry of Education, Youth and Sports of the Czech Republic
FWCI
2.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals